Identifying Importation and Asymptomatic Spreaders of Multi-drug Resistant Organisms in Hospital Settings

Jiaming Cui,Jack Heavey,Eili Klein,Gregory Madden,Anil Vullikanti,B. Aditya Prakash
DOI: https://doi.org/10.1101/2024.07.14.24310393
2024-07-15
Abstract:Healthcare-associated infections (HAIs) due to multi-drug resistant organisms (MDROs) are a signif- icant burden to the healthcare system. Patients are sometimes already infected at the time of admission to the hospital (referred to as ''importation''), and additional patients might get infected in the hospital through transmission (''nosocomial infection''). Since many of these importation and nosocomial infection cases may present no symptoms (i.e., ''asymptomatic''), rapidly identifying them is difficult since testing is limited and incurs significant delays. Although there has been a lot of work on examining the utility of both mathematical models of transmission and machine learning for identifying patients at risk of MDRO infections in recent years, these methods have limited performance and suffer from different drawbacks: Transmission modeling-based methods do not make full use of rich data contained in electronic health records (EHR), while machine learning-based methods typically lack information about mechanistic pro- cesses. In this work, we propose NeurABM, a new framework which integrates both neural networks and agent-based models (ABM) to combine the advantages of both modeling-based and machine learning- based methods. NeurABM simultaneously learns a neural network model for patient-level prediction of importation, as well as the ABM model which is used for identifying infections. Our results demonstrate that NeurABM identifies importation and nosocomial infection cases more accurately than existing methods.
Infectious Diseases (except HIV/AIDS)
What problem does this paper attempt to address?
The paper aims to address the issue of rapid identification of imported infections and asymptomatic carriers of Multi-drug Resistant Organisms (MDROs) in hospital settings. Specifically, the study focuses on the following key points: 1. **Problem Background**: Healthcare-associated infections (HAIs), especially those caused by MDROs, pose a significant threat to patient safety and incur high costs to the healthcare system. Approximately 3% of hospitalized patients acquire an HAI during their stay, leading to over 35,000 deaths annually. 2. **Challenges**: Identifying imported and hospital-acquired infection cases (including asymptomatic cases) remains challenging. Current methods include surveillance testing, machine learning approaches, and transmission model-based methods, but each has its limitations or shortcomings. 3. **Solution**: The study proposes a new framework called NeurABM, which combines neural networks and Agent-Based Models (ABM) to leverage the rich data in Electronic Health Records (EHR) and integrate epidemiological knowledge, thereby improving prediction accuracy. 4. **Implementation**: NeurABM estimates the probability of imported infection for each patient using neural networks and simulates the transmission dynamics of MRSA (Methicillin-Resistant Staphylococcus aureus) through ABM to identify imported and hospital-acquired infection cases. 5. **Experimental Results**: Validation using EHR data from the Intensive Care Units (ICUs) of the University of Virginia Hospital in the United States shows that NeurABM outperforms other machine learning or model-based baseline methods in identifying MRSA imported and hospital-acquired infection cases. In summary, the goal of this paper is to develop a new method capable of effectively identifying MDRO imports and asymptomatic carriers in hospital settings to support the implementation of infection control measures.